The past several years have seen an increasing number of new and innovative therapies entering the drug market. Many of these are precision medicines developed to treat a narrowly defined patient population, often with a previously unmet need. These treatments
Read More...
Read the complete post at http://healthaffairs.org/blog/2016/11/04/regulatory-legal-uncertainties-are-barriers-to-value-based-agreements-for-drugs/
Posted
Nov 04 2016, 09:00 AM
by
Health Affairs BlogHealth Affairs Blog